Reporting on invasive lobular breast cancer in clinical trials: a systematic review

Authors: Karen Van Baelen, Josephine Van Cauwenberge, Marion Maetens, Gabriela Beck, Ann Camden, Megan-Claire Chase, Valerie Fraser, Siobhan Freeney, Laurie Hutcheson, Julia K. Levine, Tone Lien, Rian Terveer, Claire Turner, Elzbieta Senkus, Rachel C. Jankowitz, Vincent Vandecaveye, Giuseppe Floris, Patrick Neven, Hans Wildiers, Elinor Sawyer, Anne Vincent-Salomon, Patrick W. B. Derksen, Christine Desmedt

Source: npj Breast Cancer, Vol 10, Iss 1, Pp 1-8 (2024)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2374-4677

Access URL: https://doaj.org/article/df5baec4f9804827a424183db7190118

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

Authors: Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, A. Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura J. Esserman, Hala T. Borno, Rita A. Mukhtar

Source: npj Breast Cancer, Vol 7, Iss 1, Pp 1-3 (2021)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2374-4677

Access URL: https://doaj.org/article/5ae74b962d5a4b5e99550871185eb4e4